Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
HIV Clinical Trials|January 9, 2007
Once-daily abacavir/lamivudine/zidovudine plus tenofovir for the treatment of HIV-1 infection in antiretroviral-naïve subjects: a 48-week pilot studyRichard Elion, Calvin Cohen, Edwin DeJesus, et al.AIDS Research and Human Retroviruses|July 1, 2009
Modulation of K65R selection by zidovudine inclusion: analysis of HIV resistance selection in subjects with virologic failure receiving once-daily abacavir/lamivudine/zidovudine and tenofovir DF (study COL40263)Lisa Ross, Richard Elion, Randall Lanier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal CancerAparna R Parikh, Fa-Chyi Lee, Linda Yau, et al.AIDS (London, England)|June 23, 2009
Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatmentKimberly Y Smith, Parul Patel, Derek Fine, et al.Lancet (London, England)|August 8, 2006
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trialJoseph Eron, Patrick Yeni, Joseph Gathe, et al.HIV Clinical Trials|August 14, 2003
Compact quadruple therapy with the lamivudine/zidovudine combination tablet plus abacavir and efavirenz, followed by the lamivudine/zidovudine/abacavir triple nucleoside tablet plus efavirenz in treatment-naïve HIV-infected adultsPeter J Ruane, David M Parenti, David M Margolis, et al.Journal of the National Cancer Institute|February 26, 2015
Primary tumor location as a prognostic factor in metastatic colorectal cancerFotios Loupakis, Dongyun Yang, Linda Yau, et al.The New England Journal of Medicine|December 17, 2020
Tocilizumab in Patients Hospitalized with Covid-19 PneumoniaCarlos Salama, Jian Han, Linda Yau, et al.Pageof 2